Gemzar
information and resources from the National Cancer Institute
NCI Thesaurus | Gemzar
(Other name for: gemcitabine hydrochloride)NCI Thesaurus | Gemzar
(Other name for: gemcitabine hydrochloride)
gemcitabine
For use in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer.
Eli Lilly Aug 25 1998
gemcitabine
Treatment of patients with locally advanced (nonresectable stage II or III) or metastatic (stage IV) adenocarcinoma of the pancreas. Indicated for first-line treatment and for patients previously treated with a 5-fluorouracil-containing regimen.
Eli Lilly May 15 1996
|
|
|
|
news articles
Gemzar®/Platinol® Superior to VePesid®/Platinol® in Non-Small ... Mar 29, 2006
Cancer Consultants (press release), According to an article recently published in Lung Cancer, the chemotherapy combination consisting of Gemzar® (gemcitabine) plus Platinol® (cisplatin ...
Gemzar®/Paraplatin® Followed by Taxol®/Paraplatin® as Initial ... Mar 28, 2006
Cancer Consultants (press release), According to an article recently published in the journal Gynecologic Oncology, the chemotherapy regimen consisting of Gemzar® (gemcitabine) plus Paraplatin ...
Taxotere® plus Gemzar® Provides AntiCancer Responses in ... Mar 29, 2006
Cancer Consultants (press release), ...published in the International Journal of Cancer, the combination consisting of chemotherapy agents Taxotere® (docetaxel) and Gemzar® (gemcitabine) provides ...
FDA questions Gemzar's benefit in treating ovarian cancer Mar 10, 2006
MarketWatch WASHINGTON (MarketWatch) -- The Food and Drug Administration Friday questioned the benefit of Eli Lilly and Co.'s (LLY) cancer drug Gemzar in treating advanced ...
FDA panel rejects wider use for Lilly's Gemzar Mar 14, 2006
Indianapolis Star, ...on Monday said it failed to win the backing of a Food and Drug Administration advisory committee to expand marketing of the Gemzar cancer drug for recurring ...
Lilly's Gemzar Turned Back Mar 14, 2006
TheStreet.com A bid by Eli Lilly (LLY:NYSE - commentary - research - Cramer's Take) to get Gemzar approved for ovarian cancer came up short when an advisory panel of the ...
Eli Lilly: Gemzar set for FDA rebuff Mar 14, 2006
Pharmaceutical Business Review By Staff Writer. An FDA panel has recommended against an approval of Eli Lilly's Gemzar in ovarian cancer. An FDA advisory committee ...
Gemzar Narrow Progression-Free Survival Benefit To Test Oncology ... Mar 10, 2006
FDA Advisory Committee ...again be asked to assess the clinical significance of narrow efficacy advantages during its March 13 review of an ovarian cancer indication for Lilly’s Gemzar ...
FDA Panel Recommends Rejection of Eli Lilly Drug Gemzar To Treat ... Mar 14, 2006
Kaiser network.org, An FDA panel on Monday voted 9-2 to recommend the agency reject an application by Eli Lilly to market the drug Gemzar, in combination with FDA-approved ...
Panel says no to new Gemzar use Mar 13, 2006
United Press International ROCKVILLE, Md., March 13 (UPI) -- An advisory panel to the Food and Drug Administration voted Monday not to recommend Lilly's drug Gemzar for ovarian cancer. ...
US Advisers Against New Indication for Gemzar Mar 15, 2006
Cancerpage.com, 14, 2006 (Reuters) - Advisers to the US Food and Drug Administration recommended on Monday against approving Eli Lilly & Co.'s Gemzar (gemcitabine/paclitaxel ...
Lilly shares drop after Gemzar news Mar 13, 2006
CNNMoney.com GAITHERSBURG, Md., (Reuters) - A US advisory panel said on Monday data did not support wider use of Eli Lilly & Co.'s cancer drug Gemzar, in combination with a ...
Tomudex® Plus Eloxatin® Effective in Gemzar®-Resistant ... Mar 24, 2006
Cancer Consultants (press release), Researchers from Italy have reported that approximately 50% of patients with metastatic pancreatic cancer who have failed Gemzar (gemcitabine) based regimens ...
Tomudex® Plus Eloxatin® Effective in Gemzar®-Resistant ... Mar 23, 2006
Cancer Consultants (press release), ...and Eloxatin® (oxaliplatin) provides benefit to some patients with metastatic pancreatic cancer that has stopped responding to Gemzar® (gemcitabine). ...
Lilly says hands off Gemzar Mar 14, 2006
Indianapolis Business Journal, Fresh off one blockbuster patent defense, Eli Lilly and Co. mounted another last month when it filed suit to protect its billion-dollar cancer drug Gemzar. ...
FDA ODAC Briefing Document for Gemzar Mar 10, 2006
PharmaLive.com (press release), ROCKVILLE, Md., March 13, 2006 - Attached are documents regarding the Food and Drug Administration's Oncologic Drugs Advisory Committee review of Gemzar. ...
Updated Guidelines for Treatment of Ovarian Cancer Mar 27, 2006
Cancer Consultants (press release), ...occurs more than six months after stopping chemotherapy, the following chemotherapy regimens were added as treatment options: Gemzar® (gemcitabine)/Paraplatin ...
FDA panel rejects Eli Lilly's ovarian cancer drug Mar 13, 2006
MarketWatch WASHINGTON (MarketWatch) -- A Food and Drug Administration panel Monday rejected Eli Lilly and Co.'s (LLY) cancer drug Gemzar as a proposed treatment for to ...
S KOREAN GOVT STOPS IMPORT OF GENERIC ANTI-CANCER DRUG Mar 27, 2006
TMCnet The US company holds nine patents for gemcitabine hydrochloride, a drug it sells as Gemzar, that are still effective in South Korea, despite its patent right ...
UPDATE 1-US advisers against new use of Lilly cancer drug Mar 13, 2006
Reuters ...panel of outside experts on Monday recommended against approval of Eli Lilly & Co.'s (LLY.N: Quote, Profile, Research) cancer drug Gemzar to treat advanced ...
FDA doubts benefits of Lilly cancer drug Mar 10, 2006
United Press International ROCKVILLE, Md., March 10 (UPI) -- The Food and Drug Administration Friday said it is skeptical of the benefits of Lilly's drug Gemzar for ovarian cancer. ...
FDA advisers reject Lilly cancer drug Mar 14, 2006
Trade Arabia, Advisers to the United States Food and Drug Administration (FDA) have recommended against approving Eli Lilly & Company's Gemzar to treat relapsing ovarian ...
UPDATE 2-US advisers against new use of Lilly cancer drug Mar 13, 2006
Reuters Advisers to the US Food and Drug Administration recommended on Monday against approving Eli Lilly & Co.'s (LLY.N: Quote, Profile, Research) Gemzar to treat ...
FDA panel rejects use of Lilly cancer drug Mar 13, 2006
Herald News Daily, ...and Drug Administration panel of outside experts on Monday recommended against approval of Eli Lilly & Co.‘s (NYSE:LLY - news) cancer drug Gemzar to treat ...
Ovarian cancer drug awaits FDA approval Mar 14, 2006
United Press International WASHINGTON, March 14 (UPI) -- A panel of US drug regulators reportedly is against recommending Eli Lilly's drug Gemzar as a proposed treatment for advanced ...
US FDA staff questions new use of Lilly cancer drug Mar 10, 2006
Reuters WASHINGTON, March 10 (Reuters) - Eli Lilly & Co.'s (LLY.N: Quote, Profile, Research) cancer drug Gemzar used in combination with a chemotherapy agent did not ...
Eye On Stocks For Tues., March 14, 2006 Mar 13, 2006
Forbes Eli Lilly (nyse: LLY - news - people ) shares were off slightly in after-hours trading following a negative opinion of its cancer drug Gemzar. ...
US FDA panel rejects new use of Lilly cancer drug Mar 13, 2006
Reuters A US advisory panel said on Monday data did not support wider use of Eli Lilly & Co.'s (LLY.N: Quote, Profile, Research) cancer drug Gemzar, in combination ...
FDA staff questions Lilly drug for ovarian cancer Mar 10, 2006
Reuters WASHINGTON, March 10 (Reuters) - Eli Lilly & Co.'s (LLY.N: Quote, Profile, Research) cancer drug Gemzar, used in combination with a chemotherapy agent, "has no ...
FDA panel rejects use of Lilly cancer drug Mar 13, 2006
ABC News Reuters) - A US Food and Drug Administration panel of outside experts on Monday recommended against approval of Eli Lilly & Co.'s cancer drug Gemzar to treat ...
Report: Lilly drug doesn't affect survival in ovarian cancer Mar 11, 2006
Indianapolis Star, INDIANAPOLIS -- Eli Lilly and Co.'s Gemzar has "no apparent effect" on the survival of patients with advanced ovarian cancer and leads to anemia as well as ...
Lilly drug no help for ovarian cancer: FDA staff Mar 10, 2006
Ely Times, WASHINGTON - Eli Lilly & Co.‘s (NYSE: - ) cancer drug Gemzar used in combination with a chemotherapy agent did not appear to adequately improve survival and ...
Eli Lilly shares fall on Inet Mar 13, 2006
Reuters ...fell 2.2 pct in after-hours trading after a US advisory panel said data did not support wider use of the drugmaker's cancer drug Gemzar in combination with a ...
Ovarian Cancer Clinical Endpoints Will Be Topic Of FDA/ASCO Public ... Mar 14, 2006
FDA Advisory Committee ...endpoints are a timely topic as FDA’s Oncologic Drugs Advisory Committee recently turned down an ovarian cancer indication for Lilly’s Gemzar because of ...
Lilly drug no help for ovarian cancer: FDA staff Mar 10, 2006
ABC News Mar 10, 2006 — WASHINGTON (Reuters) - Eli Lilly & Co.'s cancer drug Gemzar used in combination with a chemotherapy agent did not appear to adequately improve ...
Between 2010 and 2015 the Therapeutic Lung Cancer Drug Market is ... Mar 25, 2006
New Age Media Concepts (press release) ...chemotherapy drugs go off patent before 2012; Aventisi Taxotere (docetaxel), Bristol-Myers Squibbis Paraplatin (carboplatin) and Eli Lillyis Gemzar (gemcitabine ...
Markets Hobnob With Multi-year Highs; Nasdaq Lags Mar 18, 2006
Trading Markets, The FDA panel on Monday voted 9-to-2 against approving the company's extended use of its cancer drug GEMZAR in combination with carboplatin to treat ovarian ...
Upcoming Week In Earnings - Brokerage Earnings On Tap Mar 11, 2006
Trading Markets, The Committee is also scheduled to discuss the new drug application of Eli Lilly & Co.'s (LLY | charts | news | Powerrating) GEMZAR on Monday. ...
NCCN Announces Important Updates to Ovarian Cancer Clinical ... Mar 6, 2006
Genetic Engineering News, The regimens include gemcitabine (Gemzar, Lilly)/carboplatin (Paraplatin, Bristol Myers-Squibb) and carboplatin/paclitaxel (Taxol, Bristol Myers-Squibb). ...
Lilly Launches Phase III Trial of Targeted Cancer Agent Mar 9, 2006
news aktuell (Pressemitteilung), Alimta(R) (pemetrexed, Eli Lilly and Company) Gemzar(R) (gemcitabine HCl, Eli Lilly and Company) CeeNU(R) (lomustine [CCNU], Bristol Myers Squibb) (Logo: http ...
Erbitux® Plus Gemzar®/Paraplatin® Promising for Stage IV NSCLC Dec 19, 2005
Cancer Consultants (press release), ...to a recent article published in the Journal of Clinical Oncology, the treatment combination consisting of Erbitux (cetuximab) plus Gemzar (gemcitabine) and ...
UPDATE 1-Eli Lilly says Canada OKs Gemzar combination Nov 28, 2005
Reuters TORONTO, Nov 28 (Reuters) - Eli Lilly Canada said on Monday Canadian health regulators had approved its chemotheraphy drug, Gemzar, in combination with ...
Chemoradiation Shrinks Pancreatic Tumors to Operable Size Dec 8, 2005
MedPage Today, The trial tested a high-dose Taxotere (docetaxel) and Gemzar (gemcitabine) combination followed by twice-weekly Gemzar and external beam radiotherapy for six ...
Breast Cancer Research For the Long Term Dec 8, 2005
13WHAM-TV, ...three weeks. The third protocol looks at outcomes with chemo with a drug not yet tested for breast cancer called Gemzar. Patients ...
Induction Chemotherapy and Concomitant Chemoradiotherapy Promising ... Dec 6, 2005
Cancer Consultants (press release), ...study from the University of Alabama reported a 3-year survival rate of 45% in patients with stage III NSCLC treated with induction Gemzar® (gemcitabine) and ...
Don Peasley Dec 17, 2005
Northwest Herald, His father points with pride to his son's success in discovering two drugs – Alimta and Gemzar – marketed by Eli Lilly and amounting to more than $1 ...
Investigational Targeted Therapy May Offer Progress for Non ... Dec 10, 2005
PR Newswire (press release), Our commitment to continuous innovation in cancer care has resulted in enduring therapies such as Gemzar(R) and Alimta(R), which are already helping patients ...
Eli Lilly says Canada OKs breast-cancer treatment Nov 28, 2005
Reuters Eli Lilly Canada, a unit of US-listed Eli Lilly, said Health Canada had approved Gemzar, in combination with Taxol, as a new first-line treatment option for ...
New treatment approved for women with late-stage breast cancer Dec 2, 2005
Hamilton Mountain News, University of Toronto. "The Gemzar/paclitaxel combination seems to be less toxic than other combination therapies. This advantage ...
HMO Maccabi adds lifesaving cancer drug to insurance plan Dec 7, 2005
Ha'aretz (subscription), Three others - Gemzar, Taxol and CellCept / Prograf extend and even save lives, and are slated for a small number of patients. ...
Investigational Targeted Therapy May Offer Progress For Non ... Dec 10, 2005
news aktuell (Pressemitteilung), Gemzar(R) (gemcitabine, Eli Lilly and Company) Alimta(R) (pemetrexed, Eli Lilly and Company) (1)Lymphoma Research Foundation, "Learning About Lymphoma ...
T@P Socially and scientifically, conservatives are turning their ... Nov 20, 2005
The American Prospect, Pharmacist Robert R. Courtney pleaded guilty to diluting the cancer drugs Gemzar, made by Eli Lilly, and Taxol, made by Bristol Myers-Squibb. ...
|
|
